134 related articles for article (PubMed ID: 23291911)
1. Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.
Miller S; Bhasin N; Urrego H; Moroz K; Rowan BG; Ramayya MS; Makridakis NM
Int J Oncol; 2013 Feb; 42(2):627-34. PubMed ID: 23291911
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
[TBL] [Abstract][Full Text] [Related]
3. High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
Rzepecka IK; Szafron L; Stys A; Bujko M; Plisiecka-Halasa J; Madry R; Osuch B; Markowska J; Bidzinski M; Kupryjanczyk J
Cancer Genet; 2012 Mar; 205(3):94-100. PubMed ID: 22469508
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers.
Williams LH; Choong D; Johnson SA; Campbell IG
Clin Cancer Res; 2006 Dec; 12(23):6967-72. PubMed ID: 17145815
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
6. Methylation not a frequent "second hit" in tumors with germline BRCA mutations.
Dworkin AM; Spearman AD; Tseng SY; Sweet K; Toland AE
Fam Cancer; 2009; 8(4):339-46. PubMed ID: 19340607
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development.
Tantawy S; Mazen I; Soliman H; Anwar G; Atef A; El-Gammal M; El-Kotoury A; Mekkawy M; Torky A; Rudolf A; Schrumpf P; Grüters A; Krude H; Dumargne MC; Astudillo R; Bashamboo A; Biebermann H; Köhler B
Eur J Endocrinol; 2014 May; 170(5):759-67. PubMed ID: 24591553
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
[TBL] [Abstract][Full Text] [Related]
9. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
10. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.
Ryan A; Al-Jehani RM; Mulligan KT; Jacobs IJ
Gynecol Oncol; 1998 Jan; 68(1):14-7. PubMed ID: 9454653
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
12. Frequency of BRCA1 dysfunction in ovarian cancer.
Geisler JP; Hatterman-Zogg MA; Rathe JA; Buller RE
J Natl Cancer Inst; 2002 Jan; 94(1):61-7. PubMed ID: 11773283
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
14. The STK11/LKB1 Peutz-Jegher gene is not involved in the pathogenesis of sporadic sex cord-stromal tumors, although loss of heterozygosity at 19p13.3 indicates other gene alteration in these tumors.
Kato N; Romero M; Catasus L; Prat J
Hum Pathol; 2004 Sep; 35(9):1101-4. PubMed ID: 15343512
[TBL] [Abstract][Full Text] [Related]
15. Deoxyribonucleic acid methylation controls cell type-specific expression of steroidogenic factor 1.
Hoivik EA; Aumo L; Aesoy R; Lillefosse H; Lewis AE; Perrett RM; Stallings NR; Hanley NA; Bakke M
Endocrinology; 2008 Nov; 149(11):5599-609. PubMed ID: 18653709
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Cables 1 gene inactivation in human ovarian cancer development.
Sakamoto H; Friel AM; Wood AW; Guo L; Ilic A; Seiden MV; Chung DC; Lynch MP; Serikawa T; Munro E; Oliva E; Orsulic S; Kirley SD; Foster R; Zukerberg LR; Rueda BR
Cancer Biol Ther; 2008 Feb; 7(2):180-88. PubMed ID: 18059193
[TBL] [Abstract][Full Text] [Related]
17. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.
Köhler B; Lin L; Ferraz-de-Souza B; Wieacker P; Heidemann P; Schröder V; Biebermann H; Schnabel D; Grüters A; Achermann JC
Hum Mutat; 2008 Jan; 29(1):59-64. PubMed ID: 17694559
[TBL] [Abstract][Full Text] [Related]
18. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.
Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC
Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
